Free Trial

Treace Medical Concepts (TMCI) 10K Form and Latest SEC Filings 2026

Treace Medical Concepts logo
$1.88 +0.05 (+2.73%)
Closing price 04:00 PM Eastern
Extended Trading
$1.88 0.00 (0.00%)
As of 04:20 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Latest Treace Medical Concepts SEC Filings & Recent Activity

Treace Medical Concepts (NASDAQ:TMCI) has submitted 304+ documents to the U.S. Securities and Exchange Commission (SEC) since 2021. For investors, these filings are the primary source of verified financial data — covering everything from annual revenue and debt levels in the 10-K, to material business events in 8-K current reports, to insider buying and selling activity in Form 4 disclosures. Key figures from these filings, including revenue, earnings, and cash flow, are summarized in Treace Medical Concepts's financial statements. The most recent filing was a Form 4 submitted on April 20, 2026.

Form 4
TREACE MEDICAL CONCEPTS, INC. Reports Ownership Change on Apr. 20, 2026

Form 4 filings disclose changes in stock ownership by company insiders, including purchases, sales, grants, and option exercises.

View insider ownership

8-K
Treace Medical Concepts Files Current Report on Apr. 9, 2026

An 8-K is filed when a material corporate event occurs, such as an acquisition, leadership change, or financial update.

View filing

10-K
Treace Medical Concepts Files Annual Report on Feb. 27, 2026

The 10-K contains Treace Medical Concepts's audited financial statements, revenue, earnings, and risk factors for the prior fiscal year.

View earnings history

Treace Medical Concepts SEC Filing History

Browse Treace Medical Concepts' complete SEC filing history using the filters below. Filter by form type - 10-K, 10-Q, 8-K, Form 4, and more - or set a custom date range to find a filing.

DateFilerForm TypeView
04/20/2026 8:00 PM
Hair Mark (1725070) Reporting
Treace Medical Concepts (1630627) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
04/09/2026 6:00 AM
Treace Medical Concepts (1630627) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/06/2026 7:48 AM
Treace Medical Concepts (1630627) Filer
Form DEF 14A
04/06/2026 7:49 AM
Treace Medical Concepts (1630627) Filer
Form DEFA14A
04/06/2026 7:49 AM
Treace Medical Concepts (1630627) Filer
Form ARS
04/03/2026 8:00 PM
Hair Mark (1725070) Reporting
Treace Medical Concepts (1630627) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2026 8:00 PM
Hair Mark (1725070) Reporting
Treace Medical Concepts (1630627) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2026 8:00 PM
Treace John T. (1856380) Reporting
Treace Medical Concepts (1630627) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2026 8:00 PM
Scanlan Sean F. (1856371) Reporting
Treace Medical Concepts (1630627) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2026 8:00 PM
Elder Scot Michael (1916619) Reporting
Treace Medical Concepts (1630627) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
02/27/2026 6:10 AM
Treace Medical Concepts (1630627) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/27/2026 6:14 AM
Treace Medical Concepts (1630627) Filer
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/17/2026 8:36 PM
ARMISTICE CAPITAL, LLC (1601086) Filed by
Treace Medical Concepts (1630627) Subject
Form SCHEDULE 13G/A
02/12/2026 4:57 PM
GAGNON SECURITIES LLC (1125725) Filed by
Treace Medical Concepts (1630627) Subject
Form SCHEDULE 13G/A
02/11/2026 8:00 PM
Scanlan Sean F. (1856371) Reporting
Treace Medical Concepts (1630627) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
02/09/2026 2:13 PM
Treace Medical Concepts (1630627) Subject
WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC (1644956) Filed by
Form SCHEDULE 13G/A
01/23/2026 8:30 PM
Treace John T. (1856380) Reporting
Treace Medical Concepts (1630627) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
01/23/2026 8:30 PM
Scanlan Sean F. (1856371) Reporting
Treace Medical Concepts (1630627) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
01/23/2026 8:30 PM
Hair Mark (1725070) Reporting
Treace Medical Concepts (1630627) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
01/23/2026 8:30 PM
Elder Scot Michael (1916619) Reporting
Treace Medical Concepts (1630627) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
01/23/2026 8:30 PM
Guglielmino Gaetano (2047624) Reporting
Treace Medical Concepts (1630627) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
01/13/2026 8:30 PM
Treace John T. (1856380) Reporting
Treace Medical Concepts (1630627) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
01/13/2026 8:30 PM
Elder Scot Michael (1916619) Reporting
Treace Medical Concepts (1630627) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
01/13/2026 8:30 PM
Hair Mark (1725070) Reporting
Treace Medical Concepts (1630627) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
01/13/2026 7:54 AM
Treace Medical Concepts (1630627) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/18/2025 7:44 AM
Treace Medical Concepts (1630627) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/03/2025 8:00 PM
Guglielmino Guy (2047624) Reporting
Treace Medical Concepts (1630627) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
11/14/2025 5:27 PM
ARMISTICE CAPITAL, LLC (1601086) Filed by
Treace Medical Concepts (1630627) Subject
Form SCHEDULE 13G/A
11/12/2025 4:54 PM
Treace Medical Concepts (1630627) Subject
WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC (1644956) Filed by
Form SCHEDULE 13G
11/06/2025 3:14 PM
Treace Medical Concepts (1630627) Filer
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/28/2025 4:00 PM
Elder Scot Michael (1916619) Reporting
Treace Medical Concepts (1630627) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
10/28/2025 4:00 PM
Scanlan Sean F. (1856371) Reporting
Treace Medical Concepts (1630627) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
10/02/2025 8:30 PM
Elder Scot Michael (1916619) Reporting
Treace Medical Concepts (1630627) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
08/15/2025 11:29 AM
ARMISTICE CAPITAL, LLC (1601086) Filed by
Treace Medical Concepts (1630627) Subject
Form SCHEDULE 13G/A
08/12/2025 8:30 PM
Berutti Aaron (1871334) Reporting
Treace Medical Concepts (1630627) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
08/12/2025 8:30 PM
Scanlan Sean F. (1856371) Reporting
Treace Medical Concepts (1630627) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
08/12/2025 8:30 PM
Hair Mark (1725070) Reporting
Treace Medical Concepts (1630627) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
08/12/2025 8:30 PM
Elder Scot Michael (1916619) Reporting
Treace Medical Concepts (1630627) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
07/22/2025 4:00 PM
Scanlan Sean F. (1856371) Reporting
Treace Medical Concepts (1630627) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
05/21/2025 4:30 PM
BAKEWELL JOHN K (1183553) Reporting
Treace Medical Concepts (1630627) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
05/21/2025 4:30 PM
MOTT RICHARD W (1210226) Reporting
Treace Medical Concepts (1630627) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
05/21/2025 4:30 PM
Hanna Betsy (1885957) Reporting
Treace Medical Concepts (1630627) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
05/21/2025 4:30 PM
Kiernan Jane E (1379171) Reporting
Treace Medical Concepts (1630627) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
05/21/2025 4:30 PM
HAMILTON LAWRENCE W (1326586) Reporting
Treace Medical Concepts (1630627) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
05/21/2025 4:30 PM
Berry Lance A (1478716) Reporting
Treace Medical Concepts (1630627) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
05/21/2025 4:30 PM
Jain Deepti (1840203) Reporting
Treace Medical Concepts (1630627) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
05/21/2025 3:30 PM
Treace Medical Concepts (1630627) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/15/2025 2:19 PM
ARMISTICE CAPITAL, LLC (1601086) Filed by
Treace Medical Concepts (1630627) Subject
Form SCHEDULE 13G/A
05/12/2025 4:30 PM
Elder Scot Michael (1916619) Reporting
Treace Medical Concepts (1630627) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
05/09/2025 7:43 AM
Treace Medical Concepts (1630627) Filer
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
(Data available from 1/1/2016 forward)

Treace Medical Concepts SEC Filings - Frequently Asked Questions

Treace Medical Concepts (TMCI) has submitted 304+ filings to the SEC since 2021. You can browse the complete history or filter by form type using the tools above.

Treace Medical Concepts's fiscal year ends on December 31. The company typically files its 10-K annual report by the end of February, covering the prior fiscal year's financial results. Key financial data from these reports is available on Treace Medical Concepts's financial statements page.

The most recent filing was a Form 4 submitted on April 20, 2026. This was an insider ownership change filed by 4 - TREACE MEDICAL CONCEPTS, INC. (0001630627) (Issuer).

SEC Filing Types: 10-K, 10-Q, 8-K and More

SEC filings are legally required disclosures that public companies submit to the U.S. Securities and Exchange Commission. Unlike press releases or earnings call transcripts, these documents are filed under legal obligation — meaning the financial data they contain is audited, standardized, and subject to penalties if materially false. For investors, that makes SEC filings the most reliable primary source available for evaluating a company's true financial position.

Yes. All SEC filings are publicly available through the SEC's EDGAR database and on financial research platforms like MarketBeat. Companies are required by law to make these disclosures accessible to all investors — meaning retail investors have access to the same source documents as institutional analysts.

A 10-K is an annual report containing audited financial statements and a full review of the company's business — it is the most comprehensive filing a company makes each year. A 10-Q is a shorter, unaudited quarterly update filed three times per year between annual reports. Investors typically use the 10-K for deep fundamental analysis and the 10-Q to track whether the company is on pace with its guidance mid-year.

The most important filing for fundamental investors. Filed once per year, the 10-K contains audited financial statements, revenue and earnings trends, debt obligations, risk factors, and management's own assessment of the business. Reading the risk factors section and comparing year-over-year financials can reveal issues that don't show up in analyst summaries.

An unaudited financial update filed three times per year (the 10-K covers Q4). Investors use 10-Qs to track whether guidance is on pace, monitor changes in cash flow or inventory, and catch any mid-year shifts in business conditions before they become headline news.

Filed within four business days of a material event — earnings releases, merger announcements, executive departures, or major asset sales. Because 8-Ks are filed before media coverage catches up, they are often the fastest way to get unfiltered information directly from the company on market-moving events.

Filed within two business days whenever an executive or director buys or sells company stock. Insider purchases — especially large or clustered buys — are often interpreted as a signal of management confidence. Insider selling is more ambiguous but worth monitoring for patterns, particularly around lock-up expirations or ahead of major announcements.


Related Companies and Tools


This page (NASDAQ:TMCI) was last updated on 5/5/2026 by MarketBeat.com Staff.
From Our Partners